CDK6 and neoplasm: In a TMZ-R patient-derived xenograft mouse model, the combination of TMZ and palbociclib delayed tumor growth, and tissue analysis by RT-PCR showed the lowest level of β-catenin, Sox2, CDK6, and lncSNHG15.